[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552280":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":17,"centralContacts":22,"locations":28,"responsibleParty":48,"collaborators":50,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":17,"enrollmentInfo":65,"targetDuration":17,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":75,"overallStatus":31,"whyStopped":17,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Duke University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Care Champion Intervention","EXPERIMENTAL","The participants randomized to the intervention arm will have a care champion help to navigate their inpatient-to-outpatient transition and lipid care. They will be introduced to the intervention before discharge by the CRC who has enrolled them. This will include a virtual introduction to the care champion, delivery of contact information, and expectations around communication from the care champion in the coming months. It will also include clear education around the patient's LDL-C goals, lipid management plan, plans for re-testing, and outpatient follow-up.",[13],"Other: Care Champion Intervention",{"label":15,"type":16,"description":15,"interventionNames":17},"Standard of Care","NO_INTERVENTION",null,[19],{"type":6,"name":9,"description":20,"armGroupLabels":21,"otherNames":17},"The care champion will communicate with the patient according to an algorithm and will emphasize adherence to appropriate lipid lowering therapy, LDL-C retesting, and outpatient follow-up. The care champion will also facilitate communication of any challenges or issues with the patient's outpatient care team. Of note, the care champion will NOT be responsible for prescriptions or drug management.",[9],[23],{"name":24,"role":25,"phone":26,"phoneExt":17,"email":27},"Neha Pagidipati, MD","CONTACT","919 668 8742","neha.pagidipati@duke.edu",[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Allina Health","RECRUITING","Minneapolis","Minnesota","55407","United States","US",{"type":38,"coordinates":39},"Point",[40,41],-93.26384,44.97997,{"lat":41,"lon":40},[44],{"name":45,"role":25,"phone":46,"phoneExt":17,"email":47},"Gretchen Benson","612-863-4222","gbenson@mhif.org",{"type":49,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR",[51],{"name":52,"class":53},"Amgen","INDUSTRY","100552280","test-2-treat-can-we-improve-the-testing-and-treatment-of-high-cholesterol-in-patients-who-have-been-hospitalized-for-a-cardiac-event-by-providing-education-to-doctors-and-patients-100552280",false,"NCT06471036","Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients?","Test 2 Treat: A Randomized Implementation Trial to Improve LDL-C Management After Hospitalization for ASCVD (Atherosclerotic Cardiovascular Disease)","T2T","Inclusion Criteria:\n\n1. Age ≥ 18 years old\n2. Admitted with Type 1 NSTEMI or STEMI, and\u002For percutaneous coronary revascularization\n3. LDL-C level during admission ≥ 70 mg\u002FdL\n4. Primary care clinician and\u002For cardiologist within the health system (and with access to the same EHR) who will manage the patient in the outpatient setting\n\nExclusion Criteria:\n\n1. Determined to be highly unlikely to survive and\u002For to continue follow-up in that health system for at least 6 months (including those on hospice or with significant dementia), as identified by site investigator\n2. Underwent CABG (would therefore be discharged from surgical service)",true,"ALL","18 Years",{"count":66,"type":67},400,"ESTIMATED","INTERVENTIONAL",[70],"NA","The goal of this implementation trial is to learn if providing education to doctors and patients who have had a heart event works to prevent future heart problems. The main questions it aims to answer are:\n\n1. Does educating the doctors in a health system improve how often patients in the hospital for a heart event have their cholesterol checked?\n2. Can a \"care champion\" who calls patients who have been discharged from the hospital after a heart event help patients to achieve their cholesterol goals?\n\nResearchers will compare the number of people who achieve their cholesterol goals with the help of the care champion to the number of people who did so without the intervention to see if the care champion works to help patients lower their cholesterol.\n\nParticipants will:\n\nComplete two 15 minute surveys over the phone - 1 at enrollment and 1 at the end of the study 6 months later.",[73,74],"ASCVD","LDL-C",[76,77,78,79,80],"Implementation Science","atherosclerotic cardiovascular disease (ASCVD)","low-density lipoprotein cholesterol (LDL-C)","Intervention","care champion","2025-07-22",{"date":83,"type":84},"2025-07-25","ACTUAL",{"date":86,"type":84},"2024-10-08",{"date":88,"type":67},"2027-02-28",{"name":5,"class":6},1]